Adagio Medical Holdings, Inc Common Stock
ADGMStock
$0.53−61.33%52W
Market Cap$12.24M
P/E—
Div yield—
Beta-0.19
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-50.14%
Price vs S&P 500 (4W)-23.36%
VGM Score25.80
Market Capitalization$12.24M
Earnings Surprise History
Q1 26-0.31est. -0.30
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.14
4.13
4.13
4.11
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ADGMAdagio Medical Holdings, Inc Common Stock | — | — | D | $0.53 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Adagio Medical Holdings develops cryoablation catheter systems for treating cardiac arrhythmias, including atrial fibrillation and ventricular tachycardia. The company's proprietary technology creates contiguous, transmural lesions designed to improve treatment durability and patient outcomes. Adagio addresses both paroxysmal and persistent arrhythmias, targeting a substantial portion of the cardiac electrophysiology market.